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Phenotyping breast cancer cell lines EM-G3,
HCC1937, MCF7 and MDA-MB-231 using 2-D








Background: Transformed phenotypes are common to cell lines derived from various cancers. Proteome profiling
is a valuable tool that may reveal uncharacteristic cell phenotypes in transformed cells. Changes in expression of
glutathione S-transferases (GSTs) and other proteins interacting with glutathione (GSH) in model cell lines could be
of particular interest.
Methods: We compared the phenotypes of breast cell lines EM-G3, HCC1937, MCF7 and MDA-MB-231 using 2-D
electrophoresis (2-DE). We further separated GSH-binding proteins from the cell lines using affinity chromatography
with GSH-Sepharose 4B, performed 2-DE analysis and identified the main protein spots.
Results: Correlation coefficients among 2-DE gels from the cell lines were lower than 0.65, pointing to dissimilarity
among the cell lines. Differences in primary constituents of the cytoskeleton were shown by the 2-D protein maps
and western blots. The spot patterns in gels of GSH-binding fractions from primary carcinoma-derived cell lines
HCC1937 and EM-G3 were similar to each other, and they differed from the spot patterns of cell lines MCF7 and
MDA-MB-231 that were derived from pleural effusions of metastatic mammary carcinoma patients. Major
differences in the expression of GST P1-1 and carbonyl reductase [NADPH] 1 were observed among the cell lines,
indicating differential abilities of the cell lines to metabolize xenobiotics.
Conclusions: Our results confirmed the applicability of targeted affinity chromatography to proteome profiling and
allowed us to characterize the phenotypes of four breast cancer cell lines.
Background
Cell lines provide indispensable tools in many aspects of
laboratory research, particularly as in vitro models for
cancer research. About 6,500 new articles related to
cancer are retrieved every 30 days in PubMed, and
nearly 2,000 articles are retrieved with the key word ‘cell
line’.
Despite these advantages, the use of cell lines in can-
cer research is also disputatious [1]. A common argu-
ment for this is that cell lines are not representative of
the actual tumor diversity and heterogeneity [2].
It should be stressed that the use of different cancer
cell lines without considering their unique phenotypes is
ac o m m o np r o b l e mn e g l e c t e db ym a n yi n v e s t i g a t o r s .
For some in vitro applications (such as toxicological
assessments), it is essential to know the exact differen-
tiation state and functionality of the cells being used.
This can be approached through proteomic profiling
[3-5]. However, analysis of the complete proteome is a
complicated task. A common method for proteome ana-
lysis combines the protein separation by two-dimen-
sional electrophoresis (2-DE) with mass spectrometric
(MS) identification of selected protein spots [6,7].
Although 2-DE is capable of analyzing several thousand
proteins simultaneously, there are significant limitations
to this method. 2-DE cannot detect some potentially
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teins and proteins with higher relative molecular mass.
Another problem is detection of proteins over their nat-
ural range of abundance [8].
A combination of affinity chromatography with pro-
teomic methodology is an attractive approach that may
lead to selective pre-fractionation of groups of proteins
of interest and enable detection of less abundant pro-
teins [9,10]. The expression of glutathione S-transferases
(GSTs) and other proteins interacting with glutathione
(GSH) in model cell lines is of particular interest. GSTs
are a superfamily of detoxification enzymes, and GSH is
in the front line of cellular defense against oxidative
stress [11,12]. Levels of GST expression are potentially
important determinants in the susceptibility of tissues
to the mutagenic effects of chemical carcinogens and
t h er e s p o n s eo ft u m o r st oc h e m o t h e r a p y[ 1 1 ] .T h e
impact of GST genetic polymorphisms on human can-
cer susceptibility has been addressed by many studies
[13]. GSTs are considered protein markers for indivi-
duation of chemotherapy [14,15]. Inhibitors of GSTs
can potentially be utilized to overcome tumor cell drug
resistance, or pro-drugs can be designed that are acti-
vated by GSTs and thereby take advantage of its overex-
pression [16].
The proportion of proteins interacting with GSH and
enzymes metabolizing GSH in a cell can potentially
denote the ability of a cell to survive in unfavorable con-
ditions [12]. In this study, we set out to enrich for GSH-
binding proteins from model breast cancer cell lines.
The most widely used breast cancer cell lines are
MCF7, established in 1973 [17], and MDA-MB-231
established in 1974 [18]. Both are derived from pleural
effusions of metastatic mammary carcinoma patients.
Line MCF7 expresses markers of the luminal epithelial
phenotype of breast cells and is used as a model for
estrogen receptor-positive tumors [19]. The MDA-MB-
231 line does not express epithelial markers but con-
tains a high level of vimentin, a marker of the mesench-
ymal phenotype. It is used as a model for estrogen
receptor-negative and HER-2/neu-negative breast can-
cers [20]. More recently, several permanent cell lines
were derived from primary breast tumors. Among these,
the line HCC1937 was isolated in 1998 from a primary
carcinoma of a germ-line BRCA1 mutation carrier [21].
Cell line EM-G3, derived from a primary lesion of infil-
trating ductal breast carcinoma, was established in 2006
[22]. It expresses mixed markers for the basal and lumi-
nal phenotypes and exhibits differentiation potential.
We separated the GSH-binding proteins in these cell
lines using affinity chromatography on GSH-Sepharose
4B, performed 2-DE analysis of proteins with affinity to
GSH and identified the main protein spots.
We also compared phenotypes of the breast cell lines
MCF7, MDA-MB-231, HCC1937 and EM-G3 using 2-
DE profiling. We have previously published the 2-DE
map of the EM-G3 cell line [23]. We prepared 2-DE
maps of the MCF7, MDA-MB-231 and HCC1937 cell
lines and analyzed the positions and intensities of the
main cellular protein spots. 2-DE is shown to be an easy
tool for straightforward comparison of cell phenotypes.
Besides compelling phenotypic differences, we found
considerable differences in the content of GSTs and
other GSH-binding proteins among the selected cell
lines.
Methods
Cell culture and sample preparation
The human breast cell line EM-G3 and primary cultures
of normal mammary epithelial (NME) cells from four
donors (NME23, NME35, NME36 and NME37) were
grown as described [22,24]. The samples were obtained
from women who underwent breast reduction at the
General Faculty Hospital in Prague. The written
patient’s informed consent approved by the Ethical com-
mittee of the General Faculty Hospital in Prague was
obtained prior to surgery.
Human breast cancer cell lines MDA-MB-231, MCF7
and HCC1937 were obtained from American Type Cul-
ture Collection (ATCC). Cells were maintained in MEM
supplemented with 10% bovine serum, 2% fetal bovine
serum, 2 mM L-glutamine, 100 U/ml penicillin and
100 μg/ml streptomycin.
Cells grown to confluence were washed with PBS then
harvested by treatment with trypsin/EDTA in PBS. Cells
were pelleted by centrifugation at 800 g for 10 min. Cell
pellets were washed three times with PBS and stored in
aliquots of 5 × 10
6 cells at -70°C.
Cell pellets destined for 2-DE analysis were lysed for
1 h in denaturing lysis buffer composed of 7 M urea, 2
Mt h i o u r e a ,4 %( w / v )C H A P S ,4 0m MT r i s ,6 5m M
DTT and 2% (v/v) ampholytes (pH 9-11), using 60 μl
per 10
6 cells. The lysate was centrifuged at 16,000 g for
10 min at 20°C.
Cell pellets destined for affinity chromatography and/
or enzyme activity measurements were lysed for 30 min
in non-denaturing lysis buffer using 60 μlp e r1 0
6 cells.
The buffer was composed of 20 mM Tris-Cl pH 8.0,
0.1% (w/v) CHAPS, 0.1 M NaCl, 0.25 M sucrose, 5 mM
DTT and 1 μl per 10
6 cells of protease inhibitor cocktail
P8340 (Sigma, USA). Cells were homogenized for
30 min at 0°C and sonicated three times for 2 s. The
lysate was centrifuged at 9,000 g for 10 min at 4°C,
resuspended (using 10 μl buffer per 10
6 cells), and the
combined supernatants were centrifuged at 16,000 g for
20 min at 4°C.
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assay [25]. Samples were stored in aliquots at -70°C.
Affinity chromatography on GSH-Sepharose 4B
The lysates from 10
7 cells of each cell line (EM-G3,
MCF7, MDA-MB-231 and HCC1937) in non-denaturing
buffer were applied to GSH-Sepharose 4B (GE Health-
care, Sweden) columns (1 × 1.5 cm). Affinity chromato-
graphy was performed according to the manufacturer’s
protocol with small modifications concerning buffer
supplementation and increased concentration of GSH in
elution buffer. All procedures were performed at 4°C.
Briefly, samples were incubated for 1 hour with resin
then washed with PBS supplemented with 0.05% (v/v)
protease inhibitor cocktail and 5 mM DTT. The
adsorbed proteins were eluted with 10 mM Tris-Cl pH
8.0 containing 5 mM GSH and 0.05% (v/v) protease
inhibitor cocktail.
The course of affinity chromatography was monitored
by absorbance at 280 nm and GST activity measure-
ments. Flow through fractions and GSH-eluted fractions
were concentrated and desalted using a Microcon cen-
trifugal filter device (Millipore, USA) with a 10 kDa
exclusion limit. GST activity was determined in the
samples. The samples destined for 2-DE were then
mixed with IEF rehydration buffer (7 M urea, 2 M
thiourea, 4% (w/v) CHAPS, 50 mM DTT and 0.8% (v/v)
ampholytes (pH 3-10)).
Glutathione S-transferase activity
GST activity was measured according to the method of
Habig et al. [26] using 1-chloro-2,4-dinitrobenzene
(CDNB) as the substrate. The reaction mixture (2 ml)
contained 50 mM potassium phosphate buffer pH 6.5,
1 mM GSH and 1 mM CDNB. The mixture was incu-
bated for 10 min at 25°C and the absorbance change at
340 nm was measured using a Lambda 25 UV/VIS spec-
trophotometer (Perkin Elmer, USA). Each determination
was performed in triplicate. Specific GST activity was
calculated using the S-(2,4-dinitrophenyl) glutathione
extinction coefficient ε340 =9 . 6m M
-1·cm
-1. One unit of
enzymatic activity is defined as the amount of enzyme
that catalyzes the formation of 1 μmol product per min-
ute under the specified conditions. Specific activity was
expressed as mM product per minute per mg protein.
2-DE
The cell lysates in denaturing buffer (70 μgo r1 5μgo f
protein) were applied to 18-cm linear IPG strips pH 4-7
or to 7-cm IPG strips pH 3-10 (GE Healthcare, Sweden).
The desalted and concentrated fractions after affinity
chromatography on GSH-Sepharose 4B that had been
transferred to IEF rehydration buffer were applied to
7-cm linear IPG strips pH 3-10.
2-DE was performed as described before [23], except
12% (4% stacking gel, 19 × 22 cm or 8 × 8 cm) polya-
crylamide gels were used instead of gradient gels. The
analytical gels were stained with silver stain according to
the Bloom method as modified by Rabilloud [27].
Preparative 1-D and 2-D gels (18-cm IPG strips pH
3-10) were prepared from the fractions eluted by GSH
from the GSH-Sepharose 4B. Preparative gels were
stained with colloidal Coomassie [28].
Image analysis
Gels were scanned with a GS-800 Calibrated Densit-
ometer (Bio-Rad, Hercules, CA) at 400 dpi resolution.
Gels were analyzed using PDQuest Advanced 8.0.1 2D
Gel Analysis Software (Bio-Rad, Hercules, CA). The
locations and intensities of spots in gels from whole cell
lysates differed considerably. The gels were analyzed in
pairs to minimize any mismatching of spots that was
pertinent to complex match sets. The same detection
parameters were used for each analysis. Correlation
coefficients among cell lines were determined after man-
ual editing of spot matching. Analysis of technical repli-
cates of gels from each cell line under the same
conditions was performed.
A match set was created from gels of GSH-binding
fractions. Spot detection and matching were edited
manually. Correlation coefficients among gels were
determined. Spot intensities in 2-DE gels of GSH-bind-
ing proteins eluted from the affinity columns were esti-
mated after normalization to the total density of the
image.
Mass spectrometry and protein identification
Proteins were excised from preparative gels and in-gel
digested with trypsin. Extracted peptides were concen-
trated in a SpeedVac (Thermo Fisher Scientific, USA).
The resulting peptide mixture was analyzed by LC-MS/
MS on an LTQ-ORBITRAP mass spectrometer (Thermo
Fisher Scientific, Germany) coupled to a Rheos 2000 2-D
capillary chromatograph (Flux Instruments, Switzerland).
The first dimension column was a Symetry C18, 180 μm
×2 0m m×3μm (Waters, UK) and the second dimen-
sion column was a PepMap C18, 75 μm×1 5 0m m×
3 μm (LC Packings, USA). A data-dependent scan com-
posed of one full MS scan (resolution of 60,000) and
three CID MS/MS scans (resolution of 7,500) was used
as the mass spectrometry method. The mass tolerance
for peptide identification was 10 ppm and for searching
fragment ions was 50 ppm. The identities of all peptides
were confirmed by at least three fragment ions. Sequence
searches were performed against the Uniprot protein
database (version accessed at November 1, 2008) by Bio-
works Browser 3.3.1 SP1 and Sequest 2.0 software
(Thermo Fisher Scientific, USA).
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Cell lysates (20 μg protein) in denaturing buffer were
separated by SDS electrophoresis (12% SDS polyacryla-
mide gels) and electroblotted onto nitrocellulose mem-
branes at 12 V for 15 min in 20 mM CAPS/NaOH
buffer pH 10.3 containing 10% (v/v) methanol and 0.1%
(w/v) SDS. All incubations and washes were performed
at room temperature with 50 mM Tris/HCl buffer pH
7.5 containing 140 mM NaCl and 0.1% (v/v) Tween 20
(T-TBS). Membranes wereb l o c k e dw i t h3 %( w / v )
bovine serum albumin in T-TBS overnight. Membranes
were then incubated for 1 h with rabbit anti-actin anti-
body (A5060, Sigma, USA), mouse monoclonal anti-
vimentin antibody (RTU-VIM-V9, Novocastra, UK),
mouse monoclonal anti-CK19 antibody (NCL-CK19,
Novocastra, UK) and mouse monoclonal anti-CK13
antibody (NCL-CK13, Novocastra, UK).
Membranes were washed with T-TBS and incubated
for 1 h with anti-rabbit peroxidase-conjugated antibody
(A9169, Sigma, USA) or anti-mouse peroxidase-conju-
gated antibody (A9044, Sigma, USA). The membranes
were then washed with T-TBS and developed with dia-
minobenzidine or SuperSignal West Pico Chemilumi-
nescent substrate (Pierce, Rockford, IL) and detected
with a CCD camera Las-3000 (Fujifilm Life Science,
USA).
Results
Phenotypes of model cell lines
We prepared 2-DE protein maps for the MCF7, MDA-
MB-231 and HCC1937 cell lines in the pH range 4-7 and
compared them with our 2-DE protein map of the EM-
G3 cell line published in 2007 [23]. We performed image
analysis of the cell lines using PDQuest software.
Although the main cellular proteins could be matched
easily among the cell lines, the 2-DE protein maps dif-
fered considerably, pointing to the already known pheno-
typic differences among the lines. Quantitative
comparisons or searches for differentially expressed spots
have not been performed. Correlation coefficients among
2-D gels were used as a measure of similarity. Cell lines
were compared to each other, with a single image of each
cell line used to estimate the number of spots and corre-
lation coefficients among the lines. The correlation coef-
ficients between two technical replicates of gels from
each cell line were also determined. In total 10 analyses
were performed. The correlation coefficients are shown
in Table 1. The correlation coefficients among lines were
lower than 0.65, indicating their dissimilarity, while cor-
relation coefficients between technical replicates
exceeded a value of 0.80, indicating that high reproduci-
bility was achieved with our methodology [29].
The main cytoskeletal constituents of individual cell
lines are shown in Figure 1, together with Western blots
showing expression of actin, vimentin, CK19 and CK13.
High levels of mixed (basal and luminal) cytokeratins
were characteristic for the cell line EM-G3 [23]. The
MCF7 cells are known to express only the simple
epithelial CKs characteristic of the luminal mammary
cell phenotype [30]. MDA-MB-231 cells contain small
amounts of CKs but express the mesenchymal marker
vimentin [30]. The HCC1937 cell line does not express
basal CKs, and might be expected to express simple
CKs that are typical for luminal cells, as suggested from
our 2-DE protein maps. However, it does not express
CK19 but surprisingly contains a discernible amount of
CK13. Expression of CK13, which is not considered a
typical mammary gland cytokeratin, was observed in the
EM-G3 cell line [23].
GST activity in breast cell lines and primary cultures of
NME cells
The GST activity was measured in lysates from cells in
non-denaturing buffer. GST activities in lysates from the
permanent cell lines and four primary cultures of NME
cells were determined. The data are presented in Figure
2. The GST activities in the primary cultures ranged
between 200-500 mU/mg cell protein. Major differences
in GST activity were observed among the permanent
cell lines. The activity in MDA-MB-231 was about
200 mU/mg, the activity in EM-G3 was the highest
(912 mU/mg) while the GST activities in the lines
MCF7 and HCC1937 were negligible.
2-DE analysis of protein fractions retained on GSH-
Sepharose
Proteins fractions from lines EM-G3, HCC1937, MCF7
and MDA-MB-231 were eluted from GSH-Sepharose
columns with 5 mM GSH, concentrated and desalted by
ultrafiltration. The GST specific activity of eluted frac-
tions was about 100-200 fold higher then in cell lysates,
but the yields for the activity were only about 10-30% of
the total in the lysates before affinity chromatography.
Table 1 Correlation coefficients among cell lines and







EMG3 - 0.63 0.55 0.62 361 ±
13
0.88





- 0.46 401 ± 9 0.81
MCF7 - 344 ±
21
0.80
a) Number of spots detected in the gels from four analyses.
b) Correlation coefficient between two technical replicates of gels from a
given cell line.
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very low.
2-DE gels of fractions from cell lines eluted with
5 mM GSH from GSH-Sepharose 4B columns are
s h o w ni nF i g u r e3 .T h e2 - D Ep r o t e i nm a p so fG S H -
binding proteins contained several intensive spots and
many faint spots. The maps differed considerably among
cell lines. The main features distinguishing the protein
maps were the intense spots numbered 1 and 8 (Fig-
ure 3). We performed image analysis of the gels using
the PDQuest software. A single image of each GSH-
binding fraction was used to estimate the number of
spots and correlation coefficients among the gels. The
correlation coefficients are shown in Table 2. Although
the activity of GST was negligible in lines HCC1937 and
MCF7 as compared to lines EM-G3 and MDA-MB-231,
the overall spot patterns showed closer similarity
between lines HCC1937 and EM-G3, derived from the
primary tumors, when compared to the MDA-MB-231
and MCF7 lines derived from pleural effusions of meta-
static breast cancers.
Figure 1 Main constituents of cytoskeletons from the breast cell lines. Sections of the 2-DE gels (Mr 38-60, pI 4.6-5.7) from breast cell lines
showing the main constituents of the cytoskeleton. (A) The identities of spots are shown for cell line EM-G3. Spots corresponding to CKs are
framed. Simple CKs are in green, basal CKs are in blue and CKs atypical for mammary glands are in yellow. The data were subtracted from
Selicharova et al. [23]. Protein names are abbreviated as 40S rib.p.SA = 40S ribosomal protein SA, CK = cytokeratin, HSP = heat shock protein and
PDI = protein disulfide isomerase. (B) Estimated positions of CKs are shown for the cell lines HCC1937, MCF7 and MDA-MB-231. (C) Immunoblot
analysis. Proteins from each cell lysate were separated by 1-D SDS-PAGE and detected with rabbit anti-actin antibody and mouse monoclonal
anti-vimentin, anti-CK19 and anti-CK13 antibodies.
Figure 2 Specific activities of GST. Specific activities of GST in
four primary cultures (black columns) of NME cells (NME23, NME35,
MNE36 and NME37) and in permanent breast cell lines (white
columns).
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The fractions eluted by 5 mM GSH from GSH-Sepharose
4B contained very small amounts of protein. Only major
spots were visible in preparative gels. We succeeded in
identifying nine spots (Table 3). Seven spots were identi-
fied from 2-DE gels, and two more proteins were identi-
fied from bands in 1-D gels and their positions in 2-DE
gels were estimated (Figure 3). The relative quantities of
the spots in each cell line, as determined from the
PDQuest analysis, are presented in Table 4. The values
were normalized to total density in the gel image and are
expressed as thousandths of the total density.
The predominant protein retained on the GSH-affinity
column was GST P1-1, identified in three spots (no. 1, 2
and 3). The differences in pIs of the detected GST P1-1
isoforms might be caused by post-translational
modifications or they might rose from polymorphism of
the enzyme [Swiss-Prot:P09211]. These spots were
dominant in the EM-G3 and MDA-MB-231 cell lines
and almost undetectable in the MCF7 and HCC1937
cell lines. This is in accordance with the GST activity
measurements. We further identified GST M3-3 (spot
no. 4). This spot had a comparable intensity in each cell
line. Another large spot (no. 8) was identified as carbo-
nyl reductase [NADPH] 1. This protein was present in
the EM-G3 and HCC1937 cell lines and missing in the
MCF7 and MDA-MB-231 cell lines. We further identi-
fied elongation factors EF-1b ( s p o tn o .5 )a n dE F - 1 g
(spot no. 6) together with b-actin (spot no. 7) and lanC-
like protein 1 (LanCL 1, spot no.9).
Discussion
Our study had two goals: 1) to perform a basic compari-
son of breast cell line phenotypes by comparing protein
2-DE maps; and 2) to analyze the cellular sub-proteome
interacting with GSH in breast cell lines. Our results
confirmed the applicability of targeted affinity chromato-
graphy to proteome profiling and allowed us to charac-
terize the phenotypes of four breast cell lines.
Proteome profiling is a valuable tool providing infor-
mation about the phenotype, functionality and
Figure 3 GSH-binding proteins from the breast cell lines. Sections of the 2-DE gels (Mr 20-52, pI 4.3-9.3) for GSH-binding proteins from EM-
G3, HCC1937, MCF7 and MDA-MB-231 cell lines. Desalted and concentrated fractions from the affinity chromatography were focused on 7 cm
IPG strips pH 3-10 and separated in 12% SDS-PAGE gels. The proteins identified with numbered spots are listed in Table 3.
Table 2 Correlation coefficients among the GSH-binding
fractions and number of spots detected in each cell line
EMG3 HCC1937 MDA-MB231 MCF7 spots
EMG3 - 0.80 0.65 0.64 127
HCC1937 - 0.55 0.54 137
MDA-MB231 - 0.68 154
MCF7 - 132
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large number of proteins need to be clearly related to
specific functions. Suitable reference and control sam-
ples should be included in the analysis. This advanced
methodology for proteomic analysis and protein identifi-
cation should be combined with extensive bioinformatic
searches [4,5].
Here, we present a simplified approach that can be
utilized for basic comparisons of phenotypes for selected
cell lines. Major differences in proteomes of cell lines
selected for any application can be recognized directly
in a single 2-DE gel. Based on their similarity or dissimi-
larity a decision about usage of the cells can be made.
Analysis of whole cell lysates or of samples from tar-
geted pre-fractionation might also be used.
In this work, we took advantage of the previously
characterized proteome from the cell line EM-G3 [23].
Correlation coefficients among 2-D gels were used as a
measure of similarity [29]. Although all cell lines origi-
n a t e df r o mb r e a s tc a n c e r ,t h e i rp h e n o t y p e sw e r ec o m -
pletely different as evidenced from our analysis. When
comparing whole cell lysates, the most diverse cell lines
were MCF7 and MDA-MB-231. However, this was not
the case when we compared the GSH-binding fractions.
The spot patterns in gels from cell lines HCC1937 and
EM-G3 derived from primary carcinomas were mutually
more similar, and differed from the spot patterns in the
cell lines MCF7 and MDA-MB-231 that are derived
from pleural effusions of metastatic mammary carci-
noma patients. Extensive changes in the GSH-binding
sub-proteome may be a characteristic feature of the
metastatic cell phenotype [14,31]. Alternatively, the
changes in GSH-binding proteomes might be partially
caused by extensive cultivation of the MCF7 and MDA-
MB-231 cell lines that were established long time ago
(in 1971 respectively in 1974) compared to the relatively
“younger” cell lines HCC1937 and EM-G3.
The GST activities among breast cell lines differed
widely. An inverse correlation between estrogen recep-
tor (ER) status and GST pi expression has been reported
for breast cancer [32]. This might explain the decreased
levels of GST pi in the MCF7 cell line, which is ER
Table 3 Proteins identified from GSH-binding fractions of breast cell lines
Spot no. Accession no. Protein name Theor. Mr/pI Meas. Mr/pI Seq. cov. (%) Pept. seq.
1 P09211 GST P1-1 23,2/5,4 25/5,5 52 15
2 P09211 GST P1-1 23,2/5,4 25/5,7 47 7
3 P09211 GST P1-1 23,2/5,4 25/5,3 51 10
4 P21266 GST M3-3 26,4/5,4 27/5,6 33 8
5 P24534 EF 1-b 24,6/4,5 30/4,5 24 6
6 P26641 EF 1-g 50,0/6,3 50/nd
a 18 7
7 P60709 b-actin 41,6/5,3 44/5,3 18 7
8 P16152 Carbonyl reductase [NADPH] 1 30,2/8,5 32/8,5 20 5
9 O43813 LanCL 1 45,3/7,9 40/nd
a 52
For each protein spot we show the accession number in the Swiss-Prot database, the protein name or its abbreviation, the theoretical (Theor.) and experimental
(Meas.) relative molecular weight (in kDa) and isoelectric point (Mr/pI), the sequence coverage and the number of peptides sequenced. Protein names are
abbreviated as GST = glutathione S-transferase, EF = elongation factor, LanCL 1 = LanC-like protein 1.
a) The proteins were identified from 1-D SDS-PAGE gels, and their positions in 2-D gels were estimated according to their Mr/pI (Figure 3).
Table 4 Relative intensities of spots in the gels from GST-binding fractions
Spot no. Accession no. Protein name Relative intensity of spots
a
EM-G3 HCC1937 MDAMB231 MCF7
1 P09211 GST P1-1 49 6 48 6
2 P09211 GST P1-1 16 - 7 -
3 P09211 GST P1-1 10 - 11 3
b
4 P21266 GST M3-3 2 3 6 12
5 P24534 EF 1-b 11 26 5 2
6 P26641 EF 1-g 88 3 1
7 P60709 b-actin 17 34 24 32
8 P16152 Carbonyl reductase [NADPH] 1 15 22 1 -
9 O43813 LanCL 1 4 9 14 -
For each protein spot we show the accession number in the Swiss-Prot database, the protein name or its abbreviation. Relative intensities of spots in the gels
were estimated by PDQuest analysis. Protein names are abbreviated as GST = glutathione S-transferase, EF = elongation factor, LanCL 1 = LanC-like protein 1.
a) The values were normalized to total density in the gel image and are expressed as thousandths of total density.
b) The measured density corresponds to a proportional part of a diffuse spot that overlaps the respective position of spot no.3 (Figure 3).
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MB-231 cell lines that are ER negative. However it does
not explain the low levels of GST activity in the
HCC1937 cell line, which is also ER negative. Variability
in localization of GST pi between normal epithelial cells
and tumor cells was reported by Forrester et al. [33];
further, in some of their samples, GST pi was almost
absent from tumor tissue. Buser et al. [14] suggested
that low levels of GST activity are associated with more
aggressive and more advanced disease, while high levels
of GSTs are part of the initial phenotype of malignant
cells. We detected the highest specific activity of GST in
the cell line EM-G3, which represents a pre-malignant
population of mammary epithelial cells progenitors [22].
It is clear that expression of GST varies among breast
cancers. Exact determination of its expression is crucial
to ascertain the utility of drugs based on GST inhibitors
or activated by GST [16].
Comparison of 2-DE protein maps for proteins eluted
from GSH-Sepharose confirmed differences in the mea-
sured specific activities of GSTs and revealed deeper
divergences among cell lines.
We succeeded in identifying only the most abundant
proteins retained on the column. Faint spots were unde-
tectable in the preparative gels. The main proteins iden-
tified were GST P1-1 in three spots, GST M3-3 and
carbonyl reductase [NADPH] 1. All of these proteins are
involved in the metabolism of xenobiotics. GSTs cata-
lyze conjugation of glutathione with a wide variety of
electrophilic compounds [11]. Carbonyl reductase
[NADPH] 1 catalyzes reduction of a wide variety of car-
bonyl compounds including quinones, prostaglandins
and various xenobiotics [34]. It has high affinity for
GSH-conjugated substrates. Major divergences in
expression for these enzymes among the cell lines were
observed. Carbonyl reductase was missing in lines
MCF7 and MDA-MB-231, which are of metastatic ori-
gin. GST P1-1 was largely decreased in lines MCF7 and
HCC1937. These cell lines showed some similarity when
analyzing whole cell lysates, probably reflecting their
relation to the luminal phenotype of mammary cells as
based on their CK expression profiles [30].
Surprisingly we have not identified other typical GSH-
binding proteins, such as GSH peroxidase, GSH reduc-
tase or glyoxalase. These proteins were probably
retained on the column but not concentrated in suffi-
cient quantities for identification.
We also detected b-actin, which is one of the most
abundant proteins in cell lysates and was likely
retained on the column because it is a “sticky” protein
that interacts with many partners. Actin polymeriza-
tion is regulated by reversible glutathionylation, thus
the interaction with glutathione might be specific to a
certain extent [35].
We also identified two subunits of elongation factor 1
(EF-1): EF1-b and EF1-g. EF1-b contains a GST C-term-
inal domain and, together with EF1-δ, stimulates the
exchange of GDP that is bound to EF-1-alpha for GTP.
EF1-g contains both GST C-terminal and N-terminal
domains and probably plays a role in anchoring its com-
plex to other cellular components [36]. The role of GST
domains in elongation factor subunits is not clear. They
might be involved in the regulation of protein folding
and assembly [37].
The final protein identified was LanCL1. LanCL1 is a
mammalian ortholog of the prokaryotic enzyme lanthio-
nin synthase and its function in eukaryotes is unknown
[38]. Similar to our analysis, LanCL1 is one of the main
proteins from bovine brain lysates retained on GSH-
Sepharose [39]. It has been suggested that LanCL1
might be significant for neurodegenerative diseases and
in cellular signaling and differentiation [38].
Conclusions
To conclude, we analyzed the four breast cell lines EM-
G3, HCC1937, MCF7 and MDA-MB-231, and showed
major differences in their phenotypes especially in GSTs
activities and GSH-binding proteomes. It can be
deduced that such diversity might exist among other
cell lines and among activities of many other proteins.
Various cell lines are often used in parallel. They are
employed in determinations of bioactivities for various
compounds [40,41], in cytotoxicity measurements
[42,43] and also in studies of specific protein functions
and genes after gene manipulations [44,45]. Such com-
parisons of the behavior of cell lines should be inter-
preted considering their phenotypes. Particularly,
relevance of GST activity for toxicological studies is
obvious. Expression of GSTs in cell lines selected as
models for toxicological studies should be determined
and possibility of metabolization of tested compounds
should be considered.
The usefulness of targeted affinity in proteome profil-
ing has been demonstrated. However, when applying
this methodology certain issues should be taken into
account. The main restriction is a significant consump-
tion of a sample, while the yields of proteins retained on
affinity columns are very low. Introducing numerous
steps to sample handling is a source of contamination
and undefined protein losses. Affinity chromatography is
not a scavenger method, and complicated affinity equili-
bria for various proteins towards the ligand should be
anticipated [46]. Nevertheless, our study produced com-
pelling data that validates our approach.
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